Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Lehtinen

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|August 23, 2018
Which human papillomavirus vaccine and vaccination strategy for national programs?Matti Lehtinen
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 22, 2006
Preparations for implementing human papillomavirus vaccination should beginMatti Lehtinen
The Lancet. Infectious Diseases|August 28, 2012
Cross-protection is crucial for prophylactic HPV vaccinationMatti Lehtinen
Women'S Health (London, England)|October 7, 2009
Prophylactic human papillomavirus vaccineJorma Paavonen, Matti Lehtinen
Oncoimmunology|November 20, 2012
Sound efficacy of prophylactic HPV vaccination: Basics and implicationsMatti Lehtinen, Jorma Paavonen
Current Opinion in Obstetrics & Gynecology|August 27, 2015
Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccinationMatti Lehtinen, Dan Apter
Lancet (London, England)|November 16, 2004
Vaccination against human papillomaviruses shows great promiseMatti Lehtinen, Jorma Paavonen
The Lancet. Oncology|September 16, 2015
Fewer than three doses of HPV vaccineMatti Lehtinen, Joakim Dillner
Nature Reviews. Clinical Oncology|June 6, 2013
Clinical trials of human papillomavirus vaccines and beyondMatti Lehtinen, Joakim Dillner
Women'S Health (London, England)|October 7, 2009
First-generation vaccines against human papillomavirusJorma Paavonen, Matti Lehtinen
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Acta Obstetricia Et Gynecologica Scandinavica|August 23, 2018
Which human papillomavirus vaccine and vaccination strategy for national programs?Matti Lehtinen
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 22, 2006
Preparations for implementing human papillomavirus vaccination should beginMatti Lehtinen
The Lancet. Infectious Diseases|August 28, 2012
Cross-protection is crucial for prophylactic HPV vaccinationMatti Lehtinen
Women'S Health (London, England)|October 7, 2009
Prophylactic human papillomavirus vaccineJorma Paavonen, Matti Lehtinen
Oncoimmunology|November 20, 2012
Sound efficacy of prophylactic HPV vaccination: Basics and implicationsMatti Lehtinen, Jorma Paavonen
Current Opinion in Obstetrics & Gynecology|August 27, 2015
Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccinationMatti Lehtinen, Dan Apter
Lancet (London, England)|November 16, 2004
Vaccination against human papillomaviruses shows great promiseMatti Lehtinen, Jorma Paavonen
The Lancet. Oncology|September 16, 2015
Fewer than three doses of HPV vaccineMatti Lehtinen, Joakim Dillner
Nature Reviews. Clinical Oncology|June 6, 2013
Clinical trials of human papillomavirus vaccines and beyondMatti Lehtinen, Joakim Dillner
Women'S Health (London, England)|October 7, 2009
First-generation vaccines against human papillomavirusJorma Paavonen, Matti Lehtinen
Pageof 20